Compare CTMX & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTMX | SHBI |
|---|---|---|
| Founded | 2008 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 618.4M |
| IPO Year | 2015 | N/A |
| Metric | CTMX | SHBI |
|---|---|---|
| Price | $4.39 | $17.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $6.50 | ★ $18.75 |
| AVG Volume (30 Days) | ★ 2.8M | 182.2K |
| Earning Date | 11-06-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.68% |
| EPS Growth | ★ 50.22 | 38.21 |
| EPS | 0.24 | ★ 1.71 |
| Revenue | $113,631,000.00 | ★ $212,493,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.77 |
| P/E Ratio | $18.32 | ★ $10.52 |
| Revenue Growth | N/A | ★ 10.07 |
| 52 Week Low | $0.40 | $11.47 |
| 52 Week High | $4.62 | $19.22 |
| Indicator | CTMX | SHBI |
|---|---|---|
| Relative Strength Index (RSI) | 61.95 | 54.38 |
| Support Level | $3.86 | $17.31 |
| Resistance Level | $4.37 | $18.99 |
| Average True Range (ATR) | 0.26 | 0.45 |
| MACD | 0.02 | -0.12 |
| Stochastic Oscillator | 90.71 | 35.08 |
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.